CRIS Current Research Information System

MARASCO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.891
AS - Asia 12.794
EU - Europa 9.341
AF - Africa 841
Continente sconosciuto - Info sul continente non disponibili 736
SA - Sud America 714
OC - Oceania 34
Totale 37.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.507
IT - Italia 4.449
SG - Singapore 3.450
VN - Vietnam 3.300
CN - Cina 2.937
GB - Regno Unito 929
DE - Germania 874
HK - Hong Kong 832
SE - Svezia 676
IN - India 603
BR - Brasile 503
BD - Bangladesh 440
NL - Olanda 432
FR - Francia 394
KR - Corea 365
IE - Irlanda 284
RU - Federazione Russa 274
FI - Finlandia 271
CI - Costa d'Avorio 216
JP - Giappone 214
CA - Canada 193
ZA - Sudafrica 171
SC - Seychelles 125
CH - Svizzera 123
TG - Togo 112
PH - Filippine 85
ID - Indonesia 83
ES - Italia 82
BG - Bulgaria 74
UA - Ucraina 73
TH - Thailandia 72
MX - Messico 71
AR - Argentina 70
TR - Turchia 69
NG - Nigeria 68
JO - Giordania 65
AT - Austria 58
PL - Polonia 58
TW - Taiwan 57
BE - Belgio 51
PK - Pakistan 47
EE - Estonia 41
EC - Ecuador 36
CL - Cile 33
IQ - Iraq 33
EG - Egitto 29
LT - Lituania 29
AU - Australia 27
CD - Congo 27
GR - Grecia 24
CO - Colombia 23
HR - Croazia 23
JM - Giamaica 23
TN - Tunisia 23
MA - Marocco 22
SA - Arabia Saudita 22
CR - Costa Rica 20
MY - Malesia 19
PT - Portogallo 19
RO - Romania 19
HN - Honduras 18
UZ - Uzbekistan 16
VE - Venezuela 15
KE - Kenya 14
PY - Paraguay 13
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 10
AL - Albania 10
HU - Ungheria 10
ET - Etiopia 9
IR - Iran 9
NP - Nepal 9
TT - Trinidad e Tobago 9
KG - Kirghizistan 8
NI - Nicaragua 8
BB - Barbados 7
BO - Bolivia 7
PE - Perù 7
RS - Serbia 7
BA - Bosnia-Erzegovina 6
DK - Danimarca 6
SV - El Salvador 6
AZ - Azerbaigian 5
GT - Guatemala 5
KZ - Kazakistan 5
LV - Lettonia 5
OM - Oman 5
PR - Porto Rico 5
SN - Senegal 5
UY - Uruguay 5
BY - Bielorussia 4
DZ - Algeria 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
MD - Moldavia 4
MK - Macedonia 4
MT - Malta 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
Totale 36.544
Salva come PNG Salva come JPEG
Città #
Singapore 2.471
Ashburn 1.379
Fairfield 1.011
San Jose 912
Ho Chi Minh City 853
Hong Kong 758
Hanoi 737
Hefei 712
Southend 709
Bologna 695
Chandler 681
Milan 490
Santa Clara 426
Council Bluffs 400
Beijing 380
Rome 354
Boardman 335
New York 325
Seoul 317
Seattle 311
Houston 307
Woodbridge 292
Los Angeles 291
Dublin 282
Princeton 260
Dallas 254
Wilmington 253
Cambridge 239
Abidjan 216
Tokyo 175
Helsinki 174
Lauterbourg 166
Ann Arbor 165
Dong Ket 158
Florence 148
Da Nang 141
Frankfurt am Main 134
Haiphong 119
Lomé 112
Buffalo 111
Naples 110
Turin 107
Munich 105
Johannesburg 103
São Paulo 98
Redondo Beach 88
Brescia 85
Bern 79
Chicago 76
Bengaluru 74
Orem 72
Sofia 72
Shanghai 71
Berlin 70
Des Moines 70
Las Vegas 68
Abeokuta 64
Hyderabad 64
Amman 63
Redmond 62
Phoenix 60
Nanjing 59
San Diego 58
Palermo 56
Bremen 55
Guangzhou 55
Montreal 52
San Francisco 52
Westminster 52
London 51
Padova 49
Denver 48
North Charleston 48
Lappeenranta 47
Amsterdam 46
Brooklyn 45
Atlanta 44
Parma 44
Toronto 44
Falkenstein 42
Jakarta 41
Rimini 40
Turku 40
Brussels 39
Hải Dương 39
Redwood City 38
Jinan 37
Biên Hòa 36
Tianjin 36
Bến Tre 35
Changsha 34
Medford 34
Nuremberg 34
Modena 33
The Dalles 33
Warsaw 32
Washington 32
North Bergen 31
Chennai 30
Padua 30
Totale 21.565
Salva come PNG Salva come JPEG
Nome #
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 1.799
Functional Abdominal Bloating and Gut Microbiota: An Update 503
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 434
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 363
Management of Irritable Bowel Syndrome With Diarrhea 328
Monofocal hepatocellular carcinoma: How much does size matter? 302
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 294
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 293
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: a monocentric study 280
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 279
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 279
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 276
Ablation for hepatocellular carcinoma: beyond the standard indications 272
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 262
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders 262
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 255
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 249
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 246
Pattern of macrovascular invasion in hepatocellular carcinoma 246
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 243
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 242
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 240
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 237
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 236
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 234
The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time 230
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 228
The changing scenario of hepatocellular carcinoma in Italy: an update 227
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 225
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4- related Diseases. A Case Report 225
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 225
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 223
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 222
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 219
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 214
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 213
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 210
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 209
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 207
Eosinophilic colitis: A clinical review 204
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 203
The role of microbiota and its modulation in colonic diverticular disease 203
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 202
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 196
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 195
Gut Microbiota and Celiac Disease 194
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 194
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 193
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 192
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 191
Clinical Role of Lung Ultrasound for the Diagnosis and Prognosis of Coronavirus Disease Pneumonia in Elderly Patients: A Pivotal Study 190
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 190
A New Quantitative Classification of the Extrahepatic Biliary Tract Related to Cystic Duct Implantation 190
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 189
Gut Microbiota Characterization in Fecal Incontinence and Irritable Bowel Syndrome 188
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 187
Post COVID-19 irritable bowel syndrome 186
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 185
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up! 184
Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia 184
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 184
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 181
Concomitant Heterotopic Pancreas and Endometriosis as a Rare Cause of Ileo-Ileal Intussusception in a Young Woman with Spina Bifida: Case Report and Literature Review 181
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 180
Nutritional Management in Chronic Pancreatitis: From Exocrine Pancreatic Insufficiency to Precision Therapy 179
The Role of the FODMAP Diet in IBS 179
null 179
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 178
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 178
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 176
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 175
Diagnostic imaging for acute abdominal pain in an Emergency Department in Italy 175
Standardization of conventional chemoembolization for hepatocellular carcinoma 175
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 174
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 173
The Role of Microbiota in Upper Gastrointestinal Cancers 171
Pathophysiology and Clinical Management of Bile Acid Diarrhea 170
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 170
Nerve fiber overgrowth in patients with symptomatic diverticular disease 170
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 170
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 169
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 168
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 168
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 168
Endoscopic Ultrasound-Guided Pancreatic Cystic Fluid Biochemical and Genetic Analysis for the Differentiation Between Mucinous and Non-Mucinous Pancreatic Cystic Lesions 167
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 167
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 166
Aortic thrombosis recurrence in a Crohn's disease patient 165
Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection 165
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19 162
Microbiota modulation in disorders of gut-brain interaction 160
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
Gastric cancer staging: Is it time for magnetic resonance imaging? 159
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 157
Sedation in endoscopy: Current practices and future innovations 156
Chronic constipation: from pathophysiology to management 156
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 155
The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access System 155
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 155
Gut microbiota and metabolic syndrome. 155
Totale 22.522
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.002 0 62 95 126 293 124 121 177 184 178 1.230 412
2022/20233.297 272 446 153 391 240 279 149 190 593 94 286 204
2023/20241.784 90 211 121 135 156 348 73 125 107 157 142 119
2024/20256.604 305 736 584 500 797 354 524 315 213 636 589 1.051
2025/202616.696 1.258 1.483 1.395 1.201 1.370 755 2.393 724 2.913 1.237 1.017 950
2026/20271.890 1.138 752 0 0 0 0 0 0 0 0 0 0
Totale 37.351